Related Experiment Videos
[Therapeutic gain factor of hyperthermia]
Nihon Sanka Fujinka Gakkai Zasshi
|November 1, 1983
Summary
Hyperthermia enhances radiation's cancer-killing effects, especially when applied simultaneously. However, achieving a significant therapeutic gain factor (TGF) requires careful timing, with specific post-radiation heat applications showing promise.
Area of Science:
- Oncology
- Radiation Oncology
- Biophysics
Context:
- Investigating hyperthermia's role in cancer treatment.
- Utilizing in vivo mouse models for radiosensitization studies.
- Examining squamous cell carcinoma response to combined therapies.
Purpose:
- To evaluate the radiosensitizing effects of hyperthermia.
- To determine the therapeutic gain factor (TGF) of hyperthermia combined with radiation.
- To optimize the timing and temperature of hyperthermia for cancer therapy.
Summary:
- Hyperthermia demonstrates the strongest radiosensitizing effect when applied concurrently with radiation therapy.
- Simultaneous hyperthermia and radiation did not yield a therapeutic gain factor (TGF) greater than 1.
- Optimal therapeutic benefits were observed with specific post-radiation hyperthermia protocols (e.g., 42°C at 6 hours post-irradiation or 43°C at 4 hours post-irradiation).
Impact:
- Findings inform the clinical application of hyperthermia to improve radiation therapy outcomes.
- Establishes optimal parameters for combining hyperthermia with radiotherapy for enhanced tumor control.
- Highlights the importance of temporal sequencing in hyperthermia treatment protocols for maximizing therapeutic advantage.